key: cord-0779506-2f0nj9l4
authors: Sbrana, Francesco; Dal Pino, Beatrice; Bigazzi, Federico; Pianelli, Mascia; Luciani, Roberta; Sampietro, Tiziana
title: COVID‐19 swab collection and serological screening in lipoprotein apheresis unit
date: 2020-07-06
journal: J Clin Apher
DOI: 10.1002/jca.21810
sha: 19f2132003cfb67f9b9195676238840441793fa2
doc_id: 779506
cord_uid: 2f0nj9l4

nan

In Italian regions, nowadays are recorded 223 096 cases with a 14% of overall mortality patients from COVID-19 infections 1 and few settings are progressively learning to manage the outbreak. 2 In our Lipoprotein Apheresis (LA) Center, since 1994, we performed more than 500 treatment/y and, currently, 36 subjects (mean age 64 ± 10 years; male 25/36) are on active treatment for inherited dyslipidaemias which are often associated with comorbidities (coronary heart disease 31/36-86%, arterial hypertension 13/36-36%, overweight 12/36-33%, chronic kidney disease 3/36-8%, diabetes 2/36-6%). They are at high-risk patients 3 and it is therefore imperative to protect them and the health care team against the COVID-19 outbreak in consideration that, in LA units, several individuals are treated at the same time, in a definite area, which may be crowded.

In own unit, LA procedures are performed in agreement to guidelines and manufacturer's instructions, with a median interapheresis interval of 14 (10-14) days. All patients, except one, are from Tuscany, Italy ( Figure 1 ). We started a monitoring protocol based on: (a) telephone call performed 2 days before LA treatment, in order to fill out a questionnaire and identify clinical symptoms as fever, dry cough, headache, loss of taste or smell, and day life style information, particularly about contact with positive COVID-19 subject or travel to specific regions; (b) real-time polymerase chain reaction assays for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on upper respiratory specimens collected through swabs performed the day before LA. The swab sample was taken throughout a dedicated window by a nurse wearing an appropriate protective equipment, whereas the patient did not enter the facility but was standing outside; (c) repetition of the questionnaire and body temperature check when the patient arrives at the entrance of the facility; (d) all patients undergoing LA are wearing surgical mask and maintaining a social distanced of 1.8 m (including bed space); and (e) serological testing (Coronavirus Disease 2019 Antibody [IgM/IgG] Combined Test Kit-Medical Systems Biotechnology) is done before every LA treatment. Furthermore, the staff was included in an integrated COVID-19 infection prevention and control strategy 4 and body temperature check was performed every day at the facility entrance.

This protocol recently started and was progressively implemented, resulting in quarantine of two subjects: one with history of travel in Lombardy (the major outbreak area of Italy) and the second who was asymptomatic but in close contact of confirmed case. This second case developed positive SARS-CoV-2 swab and was maintained in quarantine at home. He restarted LA after two consecutive negative SARS-CoV-2 swabs performed at 7 days apart, and the serological tests detected IgG 

Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy

Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area

The value of hospital personnel serological screening in an integrated COVID-19 infection prevention and control strategy

A cluster of COVID-19 cases in a small Italian town: a successful example of contact tracing and swab collection

The authors declare no potential conflict of interest.

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.